1Rochefort H,Garcia M,Glondu M,et al.Cathepsin D in breast cancer:mechanisms and clinical applications,a 1999 overview[J].Clin Chim Acta,2000,291 (2):157-170.
2Fredrique V,Pierrew,Nathalie H,et al.Proteasomes regulate the duration of erythropoietin receptor activation by controlling downregulation of cell surface receptors[J].J Biol Chem,2000,275:18375-18381.
3Losch A,Tempter C,Kohlbergerp,et al.Prognostic value of cathepsin D expression and association with histomorphological subtype in breast cancer[J].Br J Cancer,1998,78:205-209.
4Wu GS,Saftig P,Peters C,et al.Potential role for cathepsin D in p53-dependent tumor suppression and chemosensitivity[J].Oncogene,1998,16(17):2177-2183.
5Zheng WQ,Looi LM,Cheah PL.A comparison of the pattern of cathepsin D expression in fibroadenoma,fibrocystic disease,preinvasive and invasive ductal breast carcinoma[J].Pathology,1999,31 (3):247-251.
6Kilukm S,Kiluk A,Woroniecki A,et al.Activity of cathepsin D in some neoplasms of gastrointestinal tract[J].Pol Merkuriusz lek,1997,2:307.
7Sis B,Sagol O,Kupeliou A,et al.Prognostic significance of matrix metalloproteinase-2,cathepsin D,and tenascin-C expression in colorectal carcinoma[J].Pathol Res Pract,2004,200:379-387.
8Kute TE,Ruvseu GB,Zbiemnski N,et al.Prognostic markers in node-negative breast cancer:a prospective study[J].Cytometry B Clin Cytom,2004,59(1):24-31.
9Glondu M,Liaudet-Coopman E,Derocq D,et al.Down-regulation of cathepsin-D expression by antisense gene transfer inhibits tumor growth and experimental lung metastasis of human breast cancer cells[J].Oncogene,2002,21 (33):5127-5134.
10Gaci Z,Bouin-Pineau MH,Gaci M,et al.Prognostic impact of cathepsin D and c-erbB-2 oncoprotein in a subgroup of node-negative breast cancer patients with low histological grade tumors[J].Int J Oncol,2001,18(4):793-800.
2OOKAWA K,KUDO T,AIZAWA S,et al.Transcriptional activation of the MUC-2 gene by p53[J].Biol Chem,2002,277(50):48270.
3GURBUZ Y,KAHLKE V,KLOPPEL G.How do gastric carcinoma classification systems relate to mucin expression patterns? An immunohistochemical analysis in a series of advanced gastric carcinomas[J]Virchows Arch,2002,440(5):505.
4BALDUS SE,HANISCH FG,PUTZ C,et al.Immunoreactivity of Lewis blood group and mucin peptide core antigens:correlations with grade of dysplasia and malignant transformation in the colorectal adenoma-carcinoma sequence[J].Histol Histopathol,2002,17(1):191.
5ROCHEFORT H.Cathepsin D in breast cancer[J].Breast Cancer Res treat,1990,16:3.
6KOU M,TEYOSHI H,TAKAYUKI T,et al.Immunohistochemical localization of Cathepsins D and E in human gastric cancer.A possible correlation with local invasive and metastatic activities of carcinoma cells[J].Human Pathology,1996,27(2):184.
7Vignon F,Capony F,Chambon M,et al.Autocrine growth stimulation of the MCF7 breast carcinoma cells by the estrogen-regulated 52K protein [J].Endocrinology,1986,118(4):1537-1542.
8Kobayashi H,Schmitt M,Goretzki L,et al.Cathepsin-D efficiently actives the soluble and the tumor cell receptor-bound form of the proenzyme urokinase-type plasminogen actor (pro-uPA) [J].Biol Chem,1991,226(8):5148-5153.
9Kristensen GB,Holm R,Abeler VM,et al.Evaluation of the prognostic significance of cathepsin D,epidermal growth factor receptor,and C-erbB-2 in early cervical squamous cell carcinoma [J].Cancer,1996,78(3):43-47.
10Sacco MG.C-erbB-2 expression and response to adjuvant therapy in women node-positive early breast cancer [J].Biochem Soc Symp,1998,47(2):171-180.
